SELECT OUR OTHER WEBSITES SELECT MARKET CONTACT US SYMBOLS GLOSSARY SEARCH Go to startpage Our knowledge Current: Improving patient outcomes with undisturbed wound healing Improving patient outcomes with undisturbed wound healing A recent QIP (Quality Improvement Project) identified 68$ savings per patient and empowered her facility to rethink their wound care budgets. Watch wound care nurse Leigh Tyson*, talk about her 'Study First: Driving the Case for Improving Hospital Wound Care', conducted at the Rose Medical Center, Denver, Colorado. *BSN, RN, CWOCN What led to the study Despite the clinicians being dissatisfied with their formulary dressing, Leigh Tyson’s who is the facilities’ sole wound care nurse, requests to use a higher quality dressing, were turned down by procurement leaders due to a higher price per item. The solution was to gather data comparing the difference in dressing performance and utilization in order to prove the clinical need and economic benefit of changing to a more efficient product. QIP Protocol During the QIP, every-shift wound assessments were suspended. The WOC nurse measured, recorded and changed dressings every 3 days. Clinical nurses recorded and replaced dressings that had to be changed outside of the protocol. Over a 6-month study period, a total of 32 wound patients were enrolled in the study. The majority of the patients’ wounds were pressure injuries and venous leg ulcers. Wounds that required a filler dressing were excluded from the QIP. Download the QIP and empower your team wound management health economics reference case Mepilex Border Flex Mepilex Border Flex All-in-one dressing that is designed to stay on and uniquely conform Learn more Mölnlycke is a world-leading medical products and solutions company that equips healthcare professionals to achieve the best patient, clinical and economic outcomes. We use cookies to improve your use and experience of Mölnlycke’s websites. By continuing to browse Mölnlycke’s site(s), you consent to the use of cookies in accordance with Mölnlycke’s applicable policies. © 2021 Mölnlycke Health Care AB. All rights reserved. Get to know us About us Products and solutions Our knowledge External links Contact us Get the details Regulatory support Products Instruction for use Media and press Policies Terms of use Cookie policy Follow Us Attention: Products shown on the Mölnlycke web sites(s) may not be available in all markets and product indication claim(s) may vary between markets. The Mölnlycke, Alldress, Arthropad, Avance, BARRIER, Biogel, Biogel Eclipse, Biogel PI Pro-Fit, Biogel Sensor, Brevet TX, Collar'n'Cuff, Drisite Easywarm, Elset, Epaderm, Exufiber, Granulox, Granudacyn, Hydrolock, EZ Derm, Hacdil, Hibi, Hibiclens, Hibidil, HiBiscrub, Indicator, Lyofoam, Mefix, Melgisorb, Mextra, Mepiform, Mepilex, Mepiseal, Mepitac, Mepitel, Mepore, Mesalt, Mesoft, Mesorb, Mestopore, Micro Indicator, NeoDerm, Normlgel, PI Indicator, PI Micro Indicator, PI Ultratouch, Polysling, Previsense, Reveal, Safetac, Setopress, Skinsense, Slinky, Steripod, Sterets, Tisept, Tubifast, Tubifast 2-way stretch, Tubigrip, Tubinette, Unisept and Unisoft trademarks, names and logos are registered globally to one or more of the Mölnlycke Health Care group of companies. Healthcare Professional Confirmation The information on the page you are about to enter is intended for healthcare professionals only. By clicking the box below you confirm that you are a healthcare professional. Yes, I am a healthcare professional Continue By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookie policy Strictly Necessary Cookies Performance Cookies Targeting Cookies Cookies Settings Save Choices Accept All Cookies